top of page
Subscribe
Latest
All News
Podcast
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Browse by category
All Posts
All News
Research
Spotlight
Industry & Products
Events & Training
Journal watch
Surgery News
Latest News
Top 10
obesity paradox
metabolic and bariatric surgery
Obesity treatment in the UK
Search
Pfizer to discontinue development oral GLP-1 receptor agonist Danuglipron
Pfizer has decided to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist,...
Browse by tag
obesity
(340)
340 posts
bariatric surgery
(194)
194 posts
type 2 diabetes
(100)
100 posts
weight loss
(85)
85 posts
bariatric and metabolic surgery
(79)
79 posts
semaglutide
(74)
74 posts
glucagon-like peptide (GLP-1) analogues
(59)
59 posts
SOARD
(47)
47 posts
covid-19
(40)
40 posts
adolescent obesity
(39)
39 posts
Obesity Surgery
(38)
38 posts
Journal watch
(37)
37 posts
diabetes
(37)
37 posts
childhood obesity
(35)
35 posts
product launch
(29)
29 posts
tirzepatide
(28)
28 posts
laparoscopic sleeve gastrectomy
(28)
28 posts
weight gain
(27)
27 posts
Roux-en-Y gastric bypass (RYGB)
(26)
26 posts
product approval
(24)
24 posts
pregnancy
(24)
24 posts
Stopping weight loss drugs linked to weight regain and reversal of beneficial heart health markers
1 hour ago
Metabolic BMI model uses AI to reveal hidden metabolic disorders
2 hours ago
Lack of support for people on weight loss drugs leaves them vulnerable to nutritional deficiencies
2 hours ago
Back to Top
bottom of page